Shift Bioscience raised $16M in a seed funding round led by Business Growth Fund to develop its AI cell simulation platform aimed at reversing age-related illnesses.
Jonathan MilnerKindred CapitalF Prime CapitalBusiness Growth Fund
Description
Shift Bioscience, a Cambridge-based startup, has announced the closure of a $16 million seed funding round. The funding, led by the Business Growth Fund, will support the development of their innovative AI cell simulation platform designed to combat age-related illnesses through cellular reprogramming.
Who to call at Shift Bioscience, and when
A new round usually means Shift Bioscience is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Shift Bioscience raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Shift Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Shift Bioscience. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Shift Bioscience
Location
Cambridge, England, United Kingdom
About
Shift Bioscience is a Cambridge-based startup founded in 2017 that is exploring how generative AI models can be utilized to reverse the ageing process by rejuvenating cells. The company aims to address age-related illnesses through cellular reprogramming and has developed an AI cell simulation platform. Their technology seeks to predict gene sets that safely rejuvenate specific cells, tackling conditions like cardiovascular disease and osteoarthritis. Shift Bioscience represents an innovative approach in the biotech sector focused on cell simulation for target discovery.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Shift Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.